LENSAR Inc Aktie News

10 ALLY Robotic Cataract Laser Systems® („ALLY System“) Platzierungen im zweiten Quartal 2026; Auftragsbestand von 13 ALLY Systems zum 30. Juni 2026 Wiederkehrende Erlöse im zweiten Quartal betrugen 13,7 Mio. USD Gesamt installiertes Laser‑Portfolio steigt auf 445 Systeme, getrieben durch 30% Wachstum bei ALLY‑Platzierungen ORLANDO, Fla., 13. Aug. 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: ...

LENSAR NASDAQ: LNSR executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing on rebuilding commercial momentum around its ALLY femtosecond laser cataract platform. Management said first-quarter results reflected that period of uncertainty, but highlighted continued growth in r...

7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026

ORLANDO, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company's first quarter 2026 financial results will be released before market open on Friday, May 8, 2026.

15 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, 2025